Glenmark sues Astellas, Triad, others over Locoid
This article was originally published in Scrip
Executive Summary
Glenmark Generics' US arm has moved court against Astellas, Triax Pharmaceuticals and three other firms over an alleged breach of an agreement concerning its generic version of Astellas Pharma/Triax Pharmaceuticals' eczema treatment, Locoid Lipocream (0.1% hydrocortisone butyrate cream).